Fwl Investment Management »

Regeneron Pharmaceuticals shares owned by Fwl Investment Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Fwl Investment Management from 13F filings

Historical chart of Fwl Investment Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Fwl Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Fwl Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 22 962.50

More positions owned by Fwl Investment Management

Microsoft Corp Stock (MSFT)
Ishares U.s. Medical Devices Etf Etf (IHI)
Vaneck Gold Miners Etf Etf (GDX)
Agnc Invt Corp Reit (AGNC)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
First Trust Nasdaq-100 Technology Sector Index Fund Etf (QTEC)
Icici Bank Adr (IBN)
Spdr Gold Shares Etf (GLD)
Datadog Inc Cl A Stock (DDOG)
Ishares Msci Japan Etf Etf (EWJ)
Alerian Mlp Etf Etf (AMLP)
Lockheed Martin Corp Stock (LMT)
Cheniere Energy Stock (LNG)
Eaton Corp Stock (ETN)
Eog Res Stock (EOG)

View all positions for Fwl Investment Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals